Skip to main content

Peer Review reports

From: EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer

Original Submission
25 Aug 2010 Submitted Original manuscript
20 Sep 2010 Reviewed Reviewer Report - Annamaria Ruzzo
26 Sep 2010 Reviewed Reviewer Report - Federica Di Nicolantonio
7 Jan 2011 Author responded Author comments - Karen-Lise Spindler
Resubmission - Version 2
7 Jan 2011 Submitted Manuscript version 2
Publishing
25 Mar 2011 Editorially accepted
25 Mar 2011 Article published 10.1186/1471-2407-11-107

You can find further information about peer review here.

Back to article page